Takeda introduces the In Their Shoes experience to the Middle East in support of the IBD patient community
USA - English
Share this article
DUBAI, UAE, June 9, 2021 /PRNewswire/ Takeda (TSE: 4502) (NYSE: TAK) has introduced the In Their Shoes platform, an award-winning, immersive simulation program to promote greater awareness and empathy for patients with Inflammatory bowel disease (IBD), a condition to describe Crohn s disease and ulcerative colitis, to a group of healthcare providers in the Middle East the first time.
The subscription-based program launched with a two-day simulation where healthcare providers and Takeda employees learned about the condition most effectively and profoundly: by living with it.
June 1, 2021, Los Angeles, California - - Baum Hedlund Aristei & Goldman attorney and vice president R. Brent Wisner was selected as a winner of Law360’s Rising Stars award for product liability. Law360 chose Attorney Wisner from a pool of more than 1,400 applicants based on several high-profile case
/PRNewswire/ Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), announces.